Table 2
Distribution of genotypes in COPD and control subjects
Leu-Leu
Leu-Pro
Pro-Pro
COPD patients (n = 165)
69 (41.6%)
83 (50.0%)
13 (8.4%)
Blood donors (n = 140)
41 (29.3%)
73 (52.1%)
26 (18.6%)
Resistant smokers (n = 76)
22 (28.9%)
39 (51.3%)
15 (19.7%)